Portal de Periódicos da CAPES

The Colorectal Cancer Control Program: partnering to increase population level screening

2011; Elsevier BV; Volume: 73; Issue: 3 Linguagem: Inglês

10.1016/j.gie.2010.12.027

1097-6779

Djenaba Joseph, Amy DeGroff, Nikki Hayes, Faye L. Wong, Marcus Plescia,

Genetic factors in colorectal cancer

Colorectal cancer (CRC) is the second leading cause of cancer deaths in the United States, killing more nonsmokers than any other cancer.1 In 2006, more than 139,000 people were diagnosed with CRC and more than 53,000 died of the disease.2 Screening can effectively decrease CRC incidence and mortality in 2 ways: first, unlike most cancers, screening offers the opportunity to prevent cancer by removing premalignant polyps; second, screening can detect CRC early when treatment is more effective.3,4 If CRC is diagnosed at early stages, the 5-year survival rate is more than 88%.